BRIDGEWAY CAPITAL MANAGEMENT, LLC - ONCOGENEX PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 57 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2015$261,000
-45.7%
215,5000.0%0.01%
-50.0%
Q3 2015$481,000
-4.2%
215,5000.0%0.01%0.0%
Q2 2015$502,000
+8.4%
215,5000.0%0.01%0.0%
Q1 2015$463,000–215,500–0.01%–
 Download
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q1 2015
NameSharesValueWeighting ↓
Virtu KCG Holdings LLC 86,824$31,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$17,0000.00%
DEUTSCHE BANK AG\ 1,405$00.00%
CITIGROUP INC 9,751$4,0000.00%
GOLDMAN SACHS GROUP INC 17,281$6,0000.00%
MORGAN STANLEY 4,250$2,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 48,944$18,0000.00%
BlackRock Inc. 927,688$334,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 6,600$2,0000.00%
Bank of New York Mellon Corp 62,846$22,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders